Based on 2 analysts giving stock ratings to Aethlon Medical Inc in the past month.
In the current month, AEMD has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. AEMD average Analyst price target in the last month is 3.250.
Based on analysts' estimates, AEMD EPS is projected to reach -2.700 in FY2027Q2, following reported EPS of -4.024 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -4.02, while Aethlon Medical IncAEMD's earnings per share (EPS) for the previous quarter was USD -1.49. EPS for the next quarter is expected at USD -2.70.